Filtros de búsqueda

Lista de obras de Pellegrino Musto

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

artículo científico publicado en 2015

90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma

artículo científico publicado en 2011

A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia

artículo científico publicado en 2016

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.

artículo científico publicado en 2015

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

artículo científico publicado en 2008

A phase II trial on alpha-interferon (alpha IFN) effect in patients with monoclonal IgM gammopathy

artículo científico publicado en 1994

A pilot characterization of human lung NSCLC by protein pathway activation mapping

artículo científico publicado en 2012

A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant

artículo científico publicado en 2011

A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.

artículo científico publicado en 2012

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

artículo científico publicado en 2009

Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia

artículo científico publicado en 2013

Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers

artículo científico publicado en 2013

Achievement of European standards by CROB-IRCCS.

artículo científico publicado en 2015

Acquired hemophilia a successfully treated with rituximab

artículo científico publicado en 2015

Advanced mast cell disease: an Italian Hematological Multicenter experience

artículo científico publicado en 2008

Advances in Azorella glabra Wedd. Extract Research: In Vitro Antioxidant Activity, Antiproliferative Effects on Acute Myeloid Leukemia Cells and Bioactive Compound Characterization

artículo científico publicado en 2020

Alliance Against Cancer, the network of Italian cancer centers bridging research and care

artículo científico publicado en 2015

Amyloid in bone marrow smears of patients affected by multiple myeloma

artículo científico publicado en 2009

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

scientific article published on 09 December 2011

An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localization

artículo científico publicado en 2013

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

artículo científico publicado en 2014

Are maintenance and continuous therapies indicated for every patient with multiple myeloma?

artículo científico publicado en 2016

Autoimmune cytopenias in chronic lymphocytic leukemia

artículo científico publicado en 2013

Autologous transplantation and maintenance therapy in multiple myeloma

artículo científico publicado en 2014

Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program

artículo científico publicado en 2010

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program

scientific article published on 14 July 2011

BRAF mutations in hairy-cell leukemia

artículo científico publicado en 2011

Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon

artículo científico publicado en 2015

Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

artículo científico publicado en 2011

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

artículo científico publicado en 2016

Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.

artículo científico publicado en 2013

Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

artículo científico publicado en 2007

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

artículo científico publicado en 2012

Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide

artículo científico publicado en 2005

Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma

artículo científico publicado en 2009

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients

artículo científico publicado en 2010

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.

artículo científico publicado en 2008

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

scientific article published on 05 February 2014

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

artículo científico publicado en 2007

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

artículo científico publicado en 2010

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival

artículo científico publicado en 2014

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2012

Cardiovascular events and intensity of treatment in polycythemia vera

artículo científico publicado en 2012

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study

Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.

artículo científico publicado en 2016

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

artículo científico publicado en 2014

Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?

artículo científico publicado en 2012

Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.

artículo científico publicado en 2016

Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience

artículo científico publicado en 2010

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines.

artículo científico publicado en 2010

Clofarabine: in search of combinations for the treatment of patients with high-risk acute myeloid leukemia

artículo científico publicado en 2008

Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes

artículo científico publicado en 2005

Compendium of FAM46C gene mutations in plasma cell dyscrasias.

artículo científico publicado en 2015

Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.

artículo científico publicado en 2013

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

artículo científico publicado en 2011

Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts

artículo científico publicado en 2008

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

artículo científico publicado en 2015

Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.

artículo científico publicado en 2009

Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study

artículo científico publicado en 1991

Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma

artículo científico publicado en 2011

Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes

artículo científico publicado en 2005

Darier sign and cutaneous involvement in mastocytosis

artículo científico publicado en 2014

Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib

scientific article published on 25 June 2011

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

artículo científico publicado en 2015

Desferrioxamine improves burst-forming unit-erythroid (BFU-E) proliferation in haemodialysis patients

artículo científico publicado en 1998

Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms.

artículo científico publicado en 2013

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome

artículo científico publicado en 2012

Dissecting chronic lymphocytic leukemia with 13q- using microRNA expression profile: Editorial for the paper "MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion".

artículo científico publicado en 2016

Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.

artículo científico publicado en 2016

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

artículo científico publicado en 2012

Efficacy and safety of bortezomib in patients with plasma cell leukemia

artículo científico publicado en 2007

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

artículo científico publicado en 2010

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes

artículo científico publicado en 2003

Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia

artículo científico publicado en 2012

Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma

artículo científico publicado en 2004

Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma

artículo científico publicado en 2011

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes

artículo científico publicado en 2010

European Myeloma Network guidelines for the management of multiple myeloma-related complications

artículo científico publicado en 2015

Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

artículo científico publicado en 2011

F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2014

FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions

artículo científico publicado en 2011

Factor XI deficiency: two novel mutations in asymptomatic Italian patients.

artículo científico publicado en 2010

Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation

artículo científico publicado en 2011

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

scientific article published on 03 October 2011

Fournier's Gangrene Complicating Hematologic Malignancies: a Case Report and Review of Licterature

artículo científico publicado en 2013

Fournier's gangrene complicating thrombocytopenia treated with steroids

artículo científico publicado en 2014

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

artículo científico publicado en 2011

Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma

artículo científico publicado en 2016

Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles

article

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

artículo científico publicado en 2015

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response

artículo científico publicado en 2017

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

artículo científico publicado en 2003

Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis

artículo científico publicado en 2004

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

artículo científico publicado en 2012

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program

artículo científico publicado en 2008

High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders

artículo científico publicado en 2015

How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions.

artículo científico publicado en 2011

Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients?

scientific article published on 01 February 2011

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems

artículo científico publicado en 2017

Imatinib-mesylate for all patients with hypereosinophilic syndrome?

artículo científico publicado en 2004

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

artículo científico publicado en 2012

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome

artículo científico publicado en 2004

Inability of activated cord blood T lymphocytes to perform Th1-like and Th2-like responses: implications for transplantation

scientific article published on 01 August 1999

Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia

artículo científico publicado en 2012

Increased risk of neurological relapse in acute lymphoblastic leukemias with high levels of cerebrospinal fluid thymidine kinase at diagnosis

artículo científico publicado en 1993

Inefficacy of imatinib-mesylate in sporadic, aggressive systemic mastocytosis

artículo científico publicado en 2004

Inflammatory Cells in Diffuse Large B Cell Lymphoma

artículo científico publicado en 2020

Insights into defibrotide: an updated review.

artículo científico publicado en 2009

Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma

scientific article published on 01 May 2006

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

scientific article published on 20 July 2004

Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia

artículo científico publicado en 2015

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

artículo científico publicado en 2017

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

artículo científico publicado en 2018

Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term study

artículo científico publicado en 2002

Lenalidomide and its role in the management of multiple myeloma

artículo científico publicado en 2008

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia

artículo científico publicado en 2013

Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone

artículo científico publicado en 2012

Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells

artículo científico publicado en 2015

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients

scientific article published on 21 September 2012

Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients

artículo científico publicado en 2016

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

artículo científico publicado en 2014

Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study.

artículo científico publicado en 2009

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

artículo científico publicado en 2014

Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma

artículo científico publicado en 2010

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

artículo científico publicado en 2009

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

artículo científico publicado en 2007

MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation

artículo científico publicado en 2015

MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.

artículo científico publicado en 2016

Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial

artículo científico publicado en 2014

Modification of QRS pattern in a patient with AL amyloidosis

artículo científico publicado en 2012

Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.

artículo científico publicado en 2010

Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine

artículo científico publicado en 2015

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation

artículo científico publicado en 2015

Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature

artículo científico publicado en 2016

Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?

artículo científico publicado en 2018

More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection

artículo científico publicado en 2014

Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))

artículo científico publicado en 2004

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy

artículo científico publicado en 2014

Myelomatous nodular lesions of the liver: diagnosis by ultrasound-guided fine-needle biopsy

artículo científico publicado en 1993

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

artículo científico publicado en 2012

No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura

artículo científico publicado en 2013

Novel Agents for the Treatment of Primary Plasma-Cell Leukemia: Lights and Shadows

artículo científico publicado en 2015

Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.

artículo científico

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

artículo científico publicado en 2006

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma

artículo científico publicado en 2005

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

artículo científico publicado en 2008

Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors

artículo científico publicado en 2012

Outcome of therapy-related myeloid neoplasms treated with azacitidine

artículo científico publicado en 2012

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

artículo científico publicado en 2013

Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial

artículo científico publicado en 2003

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

artículo científico publicado en 2011

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature

artículo científico publicado en 2007

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

artículo científico publicado en 2013

Plasma cell acid phosphatase and prognosis in multiple myeloma

scientific article published on 01 August 1994

Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review

artículo científico publicado en 2010

Possible multiple myeloma dedifferentiation following thalidomide therapy: a report of four cases

artículo científico publicado en 2004

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Grupp

artículo científico publicado en 2015

Primary Plasma Cell Leukemia: Identity Card 2016.

artículo científico publicado en 2016

Primary plasma cell leukemia 2.0: advances in biology and clinical management.

artículo científico publicado en 2016

Primary plasma cell leukemia in the era of new drugs: has something changed?

artículo científico publicado en 2011

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

artículo científico publicado en 2011

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story.

artículo científico publicado en 2009

Progress in the Treatment of Primary Plasma Cell Leukemia.

artículo científico publicado en 2016

Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance

artículo científico publicado en 2009

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study

artículo científico publicado en 2015

Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation

artículo científico publicado en 2011

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

artículo científico publicado en 2013

Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer

artículo científico publicado en 2005

Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases

artículo científico publicado en 2012

Reply to the article 'Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)' by P. Arnaud, M.-C. Escande, M. Lecuit et al. (Ann Oncol doi:10.1093/annonc/mdl369)

artículo científico publicado en 2006

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

artículo científico publicado en 2009

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

artículo científico publicado en 2015

Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.

artículo científico publicado en 2007

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma

artículo científico publicado en 2013

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

artículo científico publicado en 2011

Role of thalidomide in previously untreated patients with multiple myeloma.

scientific article published on October 2008

Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.

artículo científico publicado en 2009

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment

scientific article published on 27 September 2011

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

artículo científico publicado en 2016

Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study.

artículo científico publicado en 2015

Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.

artículo científico publicado en 2001

Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia

artículo científico publicado en 2008

Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.

artículo científico publicado en 2008

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

artículo científico publicado en 2014

Selected case from the Arkadi M. Rywlin international pathology slide series: lymphangiomatosis of the spleen associated with ipsilateral abdominopelvic and lower extremity venolymphatic malformations: a case report and review of the literature

artículo científico publicado en 2014

Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia.

artículo científico publicado en 2016

Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation

artículo científico publicado en 2003

Significance and limits of cerebrospinal fluid beta-2-microglobulin measurement in course of acute lymphoblastic leukemia

artículo científico publicado en 1988

Soluble transferrin receptor in beta-thalassaemia

artículo científico publicado en 1993

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy

artículo científico publicado en 2011

Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure

artículo científico publicado en 1999

Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up

artículo científico publicado en 2011

Targeting regulatory T cells for anticancer therapy

artículo científico publicado en 2011

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

artículo científico publicado en 2016

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

artículo científico publicado en 2011

Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant

artículo científico publicado en 2005

Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives.

artículo científico publicado en 2004

Thalidomide therapy in adult patients with myelodysplastic syndrome: a north central cancer treatment group phase II trial

artículo científico publicado en 2007

The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).

artículo científico publicado en 2016

The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A

artículo científico publicado en 2016

The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders

artículo científico publicado en 2011

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

artículo científico publicado en 2014

The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells.

artículo científico publicado en 2015

The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).

artículo científico publicado en 2014

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.

artículo científico publicado en 2013

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study

artículo científico publicado en 2013

Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.

artículo científico publicado en 2013

Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need.

artículo científico publicado en 2013

Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia

article

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms

artículo científico publicado en 2016

Validation of Vacuum-Based Refrigerated System for Biobanking Tissue Preservation: Analysis of Cellular Morphology, Protein Stability, and RNA Quality

artículo científico publicado en 2014

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

artículo científico publicado en 2009

What is better for older patients with acute myeloid leukemia?

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda